Boron neutron capture therapy (BNCT) is an effective clinical method in cancer treatment based on fission reactions and nuclear capturing. In this method, use of the best boron-containing agents for boron therapy and boron delivery agent for transfer to the infectious site are the key points for efficienct treatment. Our research indicated that calcium fructoborate(CF) was the best compound as a boroncontaining agent for boron therapy. Furthermore, studies have demonstrated that liposomes can selectively and effectively deliver large quantities of boron to cells and that the compounds delivered by liposomes have a longer cell retention time. Indeed, liposomal encapsulation technology of CF as nanostructured liposome carriers (NLCs) was extensively evaluated due to the ability of these nanovehicles for the delivery of boron compounds. In this work, the molecular composition of the CF used as a carrier supplement for cancer therapy is deeply investigated. FTIR, XRD, TG, DSC and Raman spectroscopic analyses were used for the characterization of the carrier. The experimental measurements agreed very well with the molecular formula of Ca[(C6H10O6)2B]24H2O.
INTRODUCTION 1
In 1936, Locher realized the potential of neutron capture (NC) reaction with stable isotopes in the field of medicine, and subsequently Sweet suggested that the boron NC could be used to treat brain tumors [1] . After the initial discovery, several number of research groups throughout the world continued the early groundbreaking work of Sweet, Fairchild, and especially the pioneering clinical studies of Hatanaka in Japan [2, 3] .
Boron neutron capture therapy (BNCT) was proposed for clinical treatment of cancer cells [4] . Recently, BNCT has used a number of 10 B-containing compounds to kill cancer cells selectively and also to treat the cancer via a cell-by-cell basis without affecting normal cells. The cancer cells are selectively destroyed using alpha and 7 Li particles which are generated by the 10 B(n,) 7 Li reaction [5] [6] [7] [8] [9] [10] [11] [12] [13] .
The 10 B(n,) 7 Li nuclear reactions are demonstrated as follows: He + Li + 2.792 MeV (6%) 7 4 He + Li + 2.310 MeV (94%) 7 4 Li + γ + 0.48 MeV 7 (1) 10 B chemical compound which accumulates in the cancer cell is injected to a patient's body in advance. Usually, the evolution of the 10 B concentration in cancerous and healthy tissue is obtained indirectly from blood samples taken before, after and during the BNCT treatment.
It is possible that sufficient number of 10 B atoms (about 10 9 atoms/cell) will be selectively delivered to the cancer cells and enough thermal neutrons will be absorbed by the cancer cells to sustain a lethal 10 B(n,α) 7 Li-capture reaction [14] . In this article, the therapeutic effectiveness of each BNCT and IAEA standard modeling configuration for neutron beams were considered. Important parameters, including,
were often used for preliminary assessment.
Owing to the cancer cells function, boron compounds do not enter easily and intact to cancer cells; but readily find their way into the targeted cells. Neutrons are irradiated on the affected part of the cancer, enabling selective destruction of the cancer cells containing boron by the alpha and lithium particles generated from the 10 B(n,) 7 Li reaction.
Undoubtedly, this method is a biologically efficient and targeted method in radiation treatment [15] . Since the ionization range of both the -rays and the 7 Li particles is short [~10 μm], the radiation damage occurs over a shortrange and only the cancer cells are damaged and normal tissues can be spared. The treatment finishes in the irradiation for several times [16] . Quality of life (QOL) after the treatment is generally satisfaction.
Thus, modern BNCT is actually the combination of chemo and radiotherapy, which is used in the treatment of cancer cells. The great challenge of BNCT remains to bias the retention of 10 B toward cancer cells [17] [18] [19] [20] . The selective target is a promising novelty in the field of cancer therapy. This specific Boron ray therapy is applied to cancer cells for the first time. Despite the usefulness and novelty of this strategic approach, boron carrier systems are required, as limiting the widespread application of the stated methodology. Indeed, in this study, for the development of the use of boron carrier systems, liposomal encapsulation of calcium fructoborate nanoparticles were considered as an appropriate substrate for anticancer boron compound and it was used as drug carrier system. This nano-conductor was designed to carry an anti-cancer carrier (calcium fructoborate) and its targeted release in cancer cells. In general, this is a novel approach that improves the performance, efficiency and also the quality of the clinical treatment.
Boron natural complexes are characterized as a boric acid ester with fructose, glucose, and sorbitol sugars [4, 5] . Because of molecular composition of calciu m fructoborate (CF), it has recently been demonstrated to possess an interesting anti-oxidant compound [6] , antiinflammatory [7, 8] and anti-tumoral activities [9, 10] .
During the investigation on CF applicable behavior, it was found that liposomal encapsulation of CF is an interesting developement just introduced in the cancer therapy for boron supplementation. As a matter of fact, the structures of nano-liposomes and their use as drug delivery carriers are briefly reviewed in this article.
MATERIAL AND METHODS

1. Preparation of CF
For the synthesis of CF, Miljkovic's procedure was applied [21] . Based on the developed method, boric acid (Carlo Erba) was used. Dfructose was supplied by Sigma-aldrich and CaCO3 and acetone were supplied by Merck. D-fructose (2.16 g) was dissolved in 10 ml of distilled water at room temperature, and 0.372 g boric acids was then added to this solution. Finally, 0.246 g calcium carbonate was added in small portions, under constant stirring. After the CO2 evolution was stopped, 40 ml of acetone was added to the reaction mixture. The mixture was thoroughly agitated; then let it to be separated for equilibrium.
For separation of the two layers, the mixture was separated using a separation funnel. The lower oily layer, containing the crude boron complex was treated again with additional 40 ml of acetone. Following up next step, after one hour, crystallization was induced with a glass rod, and the oil slowly turned into a white crystalline solid. Finally, the product was filtered. The developed procedure and series of reactions for the synthesis of CF are illustrated in Figure 1 . The proposed synthesis procedure, using CF as a precursor, marked as a quick and easy preparation method for the CF chain-like metaborate.
Liposomal Encapsulation Technology
Liposomes are small bubbles filled with water. The bubble is surrounded by water on the outside and filled with nano-drug inside. Moreover, their membranes are consisted of phospholipid bilayers.
There are various types of liposomes and methods for cancer therapy. The most important feature of liposomes is the fact that their phospholipid membrane is actually the same as the membrane of cells in the body. Active content is encapsulated into a liposome for improved protection, delivery, absorption, and bioavailability . Ultimately, the entrapment of the nano-drug is accomplished by the liposomal encapsulation technology (LET). Undeniably, LET represents a step forward approach in the delivery of carrier systems. Undoubtedly, a highly effective method is use of nanotechnologies to increase the efficiency of boron-containing absorption agent for boron therapy. Recently, there have been many efforts to demonstrate these nanostructures as carriers for drug release in human studies. This article describes the application of phosphatidylcholine for liposome developement. PEG has the advantage of increasing circulation lifetime of the liposomes. In addition, inclusion of PEG-ligand (for example: folate) is used to reduce aggregate formation [13] . Thus, both yield and injectability of complexes are enhanced. Scheme of nano-liposomal encapsulation of CF is demonstrated in Figure 2 . Result demonstrated that particle size of nano-liposome encapsulated CF was 96 nm.
RESULTS AND DISCUSSION
1. Quantitative Analysis
Chemical analyses are designed to determine the amounts or proportions of the components of a substance.
1. 1. FTIR and Raman Spectroscopic Studies
Borate formation was confirmed by the FTIR spectra, Raman spectra and XRD analysis of the residue. FTIR is often used to find functional groups of organic substances and chemical bonds. Figure 3 shows FTIR peaks for CF, fructose, boric acid and calcium carbonate. In the transmission spectrum of CF, the vibrational broad band of fructose is found at 1100 cm -1 is. The intensity of the beaks compared with previously reported spectral information and complements in certain aspects were reduced by the new interactions in the CF molecule. The very strong band observed at 1444 cm -1 with a shoulder at 1497 cm -1 originates in B-O stretching attributed to the external O-atoms. The other very strong absorption peak found at 1200 cm -1 is related to B-O chain stretching. The remaining characteristic peak appeared in the FTIR spectrum exhibited in Figure 3 (773 (shoulder), 739 (strong), 712 (shoulder), 688 (very strong) and 643 (strong) cm -1 ) are related to different deformational modes.
Raman spectrum is a sens itive probe for the study of biological materials with different electronic band structures depending on the number of layers. Raman spectroscopic analysis for fructose, boric acid, calcium carbonate and CF in the wave number range of 400-400 0 cm -1 was performed and the results are presented in Figure 4 . Raman spectra werere corded with a laser source, which was used at 532 nm with an average power of 64 mW. The spectra were recorded at an exposure time of 10 min and room temperature. With this technique, valuable information is obtained about the chemical composition, the secondary structure present in the macromolecules and the chemical surrounding of specific subunits. A major disadvantage of the Raman technique is the small scattering cross -section of biological molecules. As a result, high concentrations must be used. The Raman spectra data indicate a strong contribution from several bands for fructose associated with the O-H···O out-of-plane bending motions. The spectra of boric acid and calcium carbonate are very similar. The differences in the Raman spectra are not significant.
The movements of the Raman peak positions for CF were obviously presented. However, the peak at 3314 cm −1 presented in the Raman spectrum of CF is due to B-O bond. The B-O bond is broaden by the weak peaks from 1602 to 1471 cm -1 , according to the water crystallization of the structure. The diffraction maxima of free fructose was not identified in the XRD spectrum of CF. For calciu m carbonate and boric acid there were not identified ; maximal values of the X-rays diffraction were in common with those of CF.
1. Thermal Analysis
Differential Scanning Calorimetry (DSC) and Thermogravimetric Analysis (TGA) were performed in oxygen flow of 50 ml/min and at a heating rate of 5 °C/min. Sample quantities ranged between 10 and 20 mg. The obtained thermograms are shown in Figure 6 . As can be seen in this figure, there is an endothermic peak about 120 °C indicating the hydration of water, and along with this process a very weak DSC endothermal signal occurred at 67 °C. There are also small exothermic peaks in the DSC curve of CF above 300 ºC. As can be seen in Figure 6 , TGA curve consisted of three parts located between 120 and 240 °C, 240 and 420 °C and 420 and 600 °C.
These thermal degradation steps were attributed to DSC peaks at 181 °C, 315 °C, and finally a strong step at 452 °C. The total experimental mass loss was about 84%. By correlation and elemental analysis of the thermo gravimetric results obtained from experimental data, we found that no traces of precursors were observed. Furthermore, the correct molecular formula of CF was correlated as Ca[(C6H10O6)2B]24H2O, which has two times more boron than those reported in the literature [22] [23] [24] .
2. Intelligent Drug Delivery Systems Using Neutron Accelerator
Performing successful BNCT experiments needs a suitable neutron source. Important factors of the neutron beam are flux and energy that are very important in the selection of neutron source. In most centers this method is used for treatment, reactor is a neutron source, which according to characteristics of the reactor appropriate neutrons are very high. High cost of construction of a BNCT center using reactor indirectly caused seeking for other sources such as accelerator and radioisotope source directly that each has their own advantage and disadvantages [25] [26] [27] [28] [29] . There are various types of neutron sources used for cancer therapy using nanostructured liposome carriers (NLCs) for drug delivery systems; but, all of these can be placed into two distinct categories based on the needed energy: nuclear reactor and/or accelerator. In order to remedy the cancer of 10 cm 2 , 2×10 13 neutrons and low energy are needed. Indeed, assuming a remedy time ~30 minutes, neutron flux Φ > 10 9 n/(cm 2 .s) are also needed.
Neutron accelerator has applications in medicine, security, and materials analysis. While passing through the tissue of the patient, the neutrons are slowed by collisions and become low energy thermal neutrons. Neutron accelerators are neutron source devices which contain compact linear accelerators and produce neutrons by fusing isotopes of hydrogen together. The fusion reactions take place in these devices by accelerating deuterium, tritium, or a mixture of these two isotopes into a metal hydride target which also contains deuterium, tritium or a mixture of these isotopes. Fusion of deuterium atoms (D + D) and a deuterium and a tritiu m atom (D + T) results in a He-3 and He-4 ions form, separately.Also, kinetic energy of neutrons is about 2.5 MeV and 14.1 MeV, respectively. In this research we have focused on the second method as a neutron source and Monte Carlo simulation. In addition, Pb and 238 U, Alf3 and BeO were selected as neutron multipliers , moderator and reflector, respectively. Ultimately, the proposed epithermal neutron flux in suggested system is 10 9 n/cm 2 .s which is a suitable flux for BNCT applications [30] [31] [32] [33] [34] .
Based on IAEA standard modeling configuration for neutron beams [35] the α-particles and the 7 Li ions can destroy cells in mitosis. The challenge which may exist is to promote from experimental animal studies to clinical biodistribution studies, a step which has yet to be taken from experiment to clinical trials [36] [37] [38] [39] [40] .
CONCLUSION
The BNCT is an innovative technique which has several advantages: as it is almost independent on the concentration and being a binary system technique both of the two components can be adjusted independently. This may lead to a wide range of research alternatives aimed to improve the technique; but still weak feasibility exists due to reactor source, large uncertainties in dosimetric measurements and protocols 10 B compound charging. The identified correct molecular formula of fructose was Ca[(C6H10O6)2B]2·4H2O. Furthermore, CF is a biological product that can be used as boron carrier systems in human samples. Quantitative analysis of fructose, boric acid and calcium carbonate and CF showed that there are some similarities between their curves. In this research, there is a platform of liposomal encapsulation of CF as boron delivery agent that was designed and produced. 
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